TeleHealth & Digital Health

PBMs often flag telehealth claims and scrutinize the legitimacy of such scripts. When we see chargebacks based on “Invalid patient/prescriber relationship,” we know that it’s time for some legwork. We typically research (1) where the prescriber and patient were located; (2) whether prescriber was authorized to prescribe the medication in question; and (3) whether the

Federal law requires an in-person medical evaluation before a practitioner may prescribe a controlled substance. Some exceptions, however, exist. One of them is a declared public health emergency.

On January 31, 2020, the Secretary of the Department of Health and Human Services issued such a public health emergency.

On March 16, 2020, the Secretary and

One of the major changes in California pharmacy law in 2018 is the introduction of a new pharmacy type – “a remote dispensing site pharmacy.” Such pharmacies must use telepharmacy system (internet and teleconferencing) to reach critical population in medically underserved areas and dispense less than 225 prescriptions per day. The new law authorizes the

Today I want to share an article written by Stephen M. Cowherd and Russell F. Anderson (Pullman & Comley LLC, Bridgeport, CT) on Session Replay Scripts. More and more digital health companies and pharmacies are using replay tools. This article addresses privacy and compliance issues associated with such technologies.

This Article was originally published by